Table 2 Participant demographic and clinical characteristics
From: Understanding the visual function symptoms and associated functional impacts of phakic presbyopia
Description | France (N = 10) | Germany (N = 10) | USA (N = 30) | Total (N = 50) |
|---|---|---|---|---|
Participant demographic characteristics | ||||
Age (years) | ||||
Average (range) | 55.9 (41–65) | 51.1 (40–63) | 51.6 (40–65) | 52.4 (40–65) |
Sex, n (%) | ||||
Male | 2 (20.0%) | 5 (50.0%) | 13 (43.3%) | 20 (40.0%) |
Female | 8 (80.0%) | 5 (50.0%) | 17 (56.7%) | 30 (60.0%) |
Race, n (%) | ||||
Caucasian | Not appropriate to collect in France | 7 (70.0%) | 15 (50.0%) | 22 (48.9%) |
Black/African American | 1 (10.0%) | 11 (36.7) | 12 (26.7%) | |
Asian | 2 (20.0%) | – | 2 (4.4%) | |
Multi-Racial | – | – | – | |
Other—Hispanic | – | 3 (10.0%) | 3 (6.0%) | |
Missing data | – | 1 (3.3%) | 1 (2.0%) | |
Highest education level, n (%) | ||||
Some high school | 3 (30.0%) | – | 2 (6.7%) | 5 (10.0%) |
High school diploma or GED | – | 1 (10.0%) | 12 (40.0%) | 13 (26.0%) |
Some years of college | 2 (20.0%) | 4 (40.0%) | 9 (30.0%) | 15 (30.0%) |
Certificate program | – | 2 (20.0%) | – | 2 (4.0%) |
University/college degree | 3 (30.0%) | 2 (20.0%) | 6 (20.0%) | 11 (22.0%) |
Graduate or professional degree | 2 (20.0%) | 1 (10.0%) | 1 (3.3%) | 4 (8.0%) |
Work status, n (%) | ||||
Working full-time | 5 (50.0%) | 7 (70.0%) | 21 (70.0%) | 33 (66.0%) |
Working part-time | 2 (20.0%) | 1 (10.0%) | 2 (6.7%) | 5 (10.0%) |
Retired | 2 (20.0%) | 2 (20.0%) | 1 (3.3%) | 5 (10.0%) |
Full-time homemaker | 1 (10.0%) | – | 3 (10.0%) | 4 (8.0%) |
Looking for work | – | – | 1 (4.6%) | 1 (2.0%) |
Not working due to another illness | – | – | 1 (3.3%) | 1 (2.0%) |
Missing data | – | – | 1 (3.3%) | 1 (2.0%) |
Participant self-reported severity of phakic presbyopia, n (%) | ||||
Very severe | 1 (10.0%) | 1 (10.0%) | 1 (3.3%) | 3 (6.0%) |
Severe | 1 (10.0%) | 3 (30.0%) | 6 (20.0%) | 10 (20.0%) |
Moderate | 7 (70.0%) | – | 14 (46.7%) | 21 (42.0%) |
Mild | 1 (10.0%) | 6 (60.0%) | 9 (30.0%) | 16 (32.0%) |
Participant clinical characteristics (reported by recruiting clinician) | ||||
Years since diagnosed, average (range)a | 10.4 (0.5–20.9) | 7.3 (1–17.1) | 7.6 (0.2–34.6) | 8.1 (0.2–34.6) |
Visual Acuity score of left eye (decimal), average (range)1 | 0.92 (0.6–1.0) | 0.67 (0.5–0.8) | 0.63 (0.2–1.0) | 0.69 (0.2–1.0) |
Visual Acuity score of right eye (decimal), average (range)1 | 0.92 (0.6–1.0) | 0.64 (0.4–0.8) | 0.62 (0.3–1.0) | 0.69 (0.3–1.0) |
Severity of participants’ binocular DCNVA at 40 cm, n (%) | ||||
Mild | 2 (20.0%) | 6 (60.0%) | 14 (46.7%) | 22 (44.0%) |
Moderate-severe | 3 (30.0%) | 4 (40.0%) | 16 (53.3%) | 23 (46.0%) |
Information not available | 5 (50.0%) | – | – | 5 (10.0%) |
Severity of participants’ near ADD, n (%) | ||||
Mild | 3 (30.0%) | 6 (60.0%) | 14 (46.7%) | 23 (46.0%) |
Moderate-severe | 7 (70.0%) | 4 (40.0%) | 16 (53.3%) | 27 (54.0%) |
Clinician reported myopia/near sightedness†, n (%) | ||||
None | 6 (60.0%) | 5 (50.0%) | 18 (86.4%) | 29 (58.0%) |
Mild | 2 (20.0%) | – | 2 (6.7%) | 4 (8.0%) |
Moderate | 1 (10.0%) | – | 2 (6.7%) | 4 (8.0%) |
High | 1 (10.0%) | – | 3 (10.0%) | 4 (8.0%) |
Missing data | – | 5 (50.0%) | 5 (4.5%) | 10 (20.0%) |
Concomitant conditions, n (%)* | ||||
Yes: | 1 (10.0%) | – | 2 (6.7%) | 3 (6.0%) |
Posterior detachment of the left vitreous | 1 (10.0%) | 1 (2.0%) | ||
Asthma | 1 (3.3%) | 1 (2.0%) | ||
Glaucoma | 1 (3.3%) | 1 (2.0%) | ||
COPD | 1 (3.3%) | 1 (2.0%) | ||
Current treatment for phakic presbyopia, n (%) | ||||
Glasses ~ : | 7 (70.0%) | 5 (50.0%) | 22 (73.3%) | 34 (68.0%) |
Unspecified | 1/7 (14.3%) | 5/5(100%) | 14/22 (63.6%) | 20/34 (58.8%) |
Single vision | 2/7 (28.6%) | – | 4/22 (18.2%) | 6/34 (17.6%) |
Multifocal | 4/7 (57.1%) | – | 2/22 (9.1%) | 6/34 (17.6%) |
Bifocals | – | – | 2/22 (9.1%) | 2/34 (5.9%) |
Contact lenses | – | 5 (50.0%) | 2 (6.7%) | 7 (14.0%) |
Myopia treatment reported only | 1 (10.0%) | – | 3 (10.0%) | 4 (8.0%) |
Missing data^ | 3 (30.0%) | – | 5 (16.7%) | 8 (16.0%) |